TSE •
Healthcare •
Biotechnology •
Quote as of 09/09/2026 13:17
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeTSE
Market Capitalization6,807.59 mln
Float9.10 mln
Earnings Date06/12/2025
EPS
3.55
Stretched
P / E
91.83
Speculative
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2.71
Likely reliable
Relative Strength
5
/ 100
Severely lagging
Debt / Equity
0.00
Debt-free
Business Description
CellSource Co. Ltd. is a Japanese company founded in 2015 and based in Shibuya that helps medical facilities deliver regenerative treatments to patients. Its core work involves isolating stem cells from body fat and creating platelet-rich plasma from blood samples, which are used in therapeutic procedures. Beyond clinical support, the company also sells skincare and anti-aging products made from human stem cell-derived ingredients.
